DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Leung DH, Yao B, Viani RM. et al.
ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infection.
Journal of hepatology 2017;
66: S300-S301
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.